Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
66.7M
-
Shares change
-
-1.68M
-
Total reported value, excl. options
-
$343M
-
Value change
-
-$10.2M
-
Put/Call ratio
-
0.94
-
Number of buys
-
67
-
Number of sells
-
-63
-
Price
-
$5.14
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q1 2024
173 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q1 2024.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.7M shares
of 92.2M outstanding shares and own 72.4% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.01M shares), PFM Health Sciences, LP (6.48M shares), STATE STREET CORP (6.35M shares), Avidity Partners Management LP (5.79M shares), VANGUARD GROUP INC (4.11M shares), Point72 Asset Management, L.P. (3.59M shares), ALKEON CAPITAL MANAGEMENT LLC (2.74M shares), Elmwood Wealth Management, Inc. (2.36M shares), Paradigm Biocapital Advisors LP (2.17M shares), and DIMENSIONAL FUND ADVISORS LP (2.09M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.